CDC recommends rationing of RSV shot due to shortages

In a health alert, the CDC said clinicians should prioritize available doses for babies at highest risk from respiratory syncytial virus.

October 24, 2023 Check out STAT+

Sponsored By

Mike Reddy for STAT STAT+ | For Parkinson's disease, advances spurred by Apple Watch offer a glimmer of hope After nearly a decade of development, Apple Watch is now being leveraged on an entirely new health frontier: Parkinson's disease. By Mario Aguilar CDC recommends rationing of RSV shot due to shortages In a health alert, the CDC said clinicians should prioritize available doses for babies at highest risk from respiratory syncytial virus. By Helen Branswell AstraZeneca, maker of FluMist, seeks to allow at-home administration of vaccine If AstraZeneca's application is approved by the FDA, the vaccine would be ordered and delivered after consultation with a medical professional. By Helen Branswell YUICHI YAMAZAKI/AFP via Getty Images The official definition of infertility now includes LGBTQ+ and single people The decision by ASRM is intended to support same-sex couples and single patients who currently see their fertility treatment claims declined. By Annalisa Merelli STAT+ | With an old approach but new energy, ADCs take center stage as promising cancer treatments ADCs are designed to deliver chemotherapy directly to tumors, possibly one day replacing the blunt-force toxic therapies. By Andrew Joseph STAT+ | A controversial new study examines traditional Chinese medicine's potential cardiac benefits JAMA struggled with whether to publish a new study on potential cardiac benefits of tongxinluo, a traditional Chinese medicine compound. By Annalisa Merelli and Matthew Herper Adobe Opinion: Do dementia villages actually work? We just don't know While promising in theory, it's not clear dementia villages actually work, or if they are a feasible option for everyone. By Kristina Carvalho STAT+ | 'Missed opportunities': Why a U.K. government plan to disclose financial ties between pharma and docs may fall short The U.K. government plans to create a database similar to one in the U.S. that was set up in response to concerns about industry influence. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser